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Intracellular bacterial pathogens exploit host cells as a part of their lifecycle, and they do so 
by manipulating host cell signaling events. Many such bacteria are known to produce effector 
proteins that promote cell invasion, alter membrane trafficking, and disrupt signaling cascades. 
This review highlights recent advances in our understanding of signaling pathways involved in 
host cell responses to Francisella tularensis, a facultative Gram-negative intracellular pathogen 
that causes tularemia. We highlight several key pathways that are targeted by Francisella, with 
a focus on the phosphatidylinositol 3-kinase/Akt pathway. Lastly, we discuss the emerging role 
of microRNAs (miRs), specifically miR-155, as a key regulator of host signaling and defense.
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pathogen for biodefense purposes, and tremendous advances have 
been made in recent years (Oyston et al., 2004; Elkins et al., 2007; 
Santic et al., 2010).
One of the most interesting aspects of infection with F. tularensis 
is that there is a lack or delay of inflammatory response during 
the early stages of infection (Andersson et al., 2006; Bosio et al., 
2007). Even though this pathogen is Gram-negative, the lipopoly-
saccharide (LPS) is modified in such a way that it does not activate 
toll-like receptor (TLR) 4 (Hajjar et al., 2006; Gunn and Ernst, 
2007). Additionally, F. tularensis can suppress the host’s ability to 
respond to pro-inflammatory signals (Telepnev et al., 2003, 2005; 
Bosio et al., 2007), thus demonstrating that it does not merely evade 
host cell immune responses. Indeed, genomewide studies on the 
effect of F. tularensis on human phagocytes shows a broad sup-
pression of numerous signaling pathways including TLR signaling, 
autophagy, major histocompatibility complex (MHC) presentation, 
interferon signaling, and phosphatidylinositol 3-kinase (PI3K) sig-
naling (Butchar et al., 2008).
Bacterial entry into phagocytes
Internalization of Francisella by human phagocytes occurs though 
a unique process termed “looping phagocytosis” (Clemens and 
Horwitz, 2007). Optimal phagocytosis of Francisella requires an 
intact complement pathway, as internalization is dramatically 
reduced in the absence of complement (Lofgren et al., 1983; 
Balagopal et al., 2006; Clemens and Horwitz, 2007). However, the 
bacterium itself is resistant to complement-mediated lysis though 
its LPS O antigen (Clay et al., 2008). Other receptors such as the 
scavenger receptor (Pierini, 2006) and mannose receptor (Balagopal 
et al., 2006; Schulert and Allen, 2006) have been implicated in pro-
moting bacterial uptake. Fc receptors also play a role, aiding both 
internalization of bacteria (Balagopal et al., 2006) and host protec-
tion (Kirimanjeswara et al., 2007).
introduction
Successful intracellular pathogens must have mechanisms to usurp 
their hosts’ normal functions and defenses, thereby creating a favo-
rable environment. For example, Legionella pneumophila secrete 
type IV effectors that form a permissive niche (Berger et al., 1994) 
and Yersinia pestis disrupts host nuclear factor kappa B (NF-κB) 
signaling via the Yop J proteins (Zhou et al., 2005). However, each 
pathogen can use slightly – or vastly – different mechanisms to 
conquer the complex signaling pathways that orchestrate the host 
response. A better understanding of these responses and the meth-
ods by which pathogens defeat them will fuel the generation of 
novel therapeutics.
 Francisella tularensis is a Gram-negative bacterial pathogen 
and is the causative agent of tularemia. The highest-virulence F. 
tularensis subspecies tularensis requires as few as 10 colony form-
ing units to cause disease and death in humans (Sjostedt, 2007). 
Because of this it has been classified as a category A select agent by 
the United States Centers for Disease Control. However, there are 
also lower-virulence subspecies and strains, such as F. tularensis 
subspecies novicida and the live vaccine strains (LVS) of F. tula-
rensis subspecies holarctica. These subspecies are used extensively 
for research because they lead to disease in mice that resembles 
human tularemia, their intracellular lifecycles are similar to that of 
F. tularensis tularensis, and they present minimal risk to humans. 
Since 2001 there has been a renewed interest in the study of this 
Abbreviations: AIM-2, absent in melanoma 2; ERK, extracellular signal-regulated 
kinase; GSK3β, glycogen synthase kinase 3 beta; LPS, lipopolysaccharide; MHC, 
major histocompatibility complex; MyD88, myeloid differentiation primary re-
sponse gene (88); NF-κB, nuclear factor kappa B; PI3K, phosphatidylinositol 
3-kinase; PTEN, phosphatase and tensin homolog; ripA, required for intracellu-
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agent carried a reduced bacterial burden (Chiu et al., 2009). Hence, 
it is likely that autophagy is beneficial to the host and serves to 
promote intracellular control of bacteria by sequestering them into 
vacuoles after escape. It is important to note that many autophagy-
related genes are downregulated during F. novicida and F. tularen-
sis infection (Butchar et al., 2008; Cremer et al., 2009a), raising 
the possibility that Francisella is also antagonizing this means of 
host defense.
recognition of Francisella and triggering of the 
inflammatory response
During the infection cycle of Francisella there is activation of 
extracellular and cytosolic pattern recognition receptors. At the 
cell surface and within the phagosome, TLR2/myeloid differentia-
tion primary response gene (88) (MyD88) signaling is essential 
for activating NF-κB and for producing pro-inflammatory media-
tors (Katz et al., 2006). CD14 is also required for effective TLR 
signaling upon F. tularensis infection (Chase and Bosio, 2010). 
After escape from the phagosome the bacteria gain access to the 
cytosol and activate the inflammasome (Mariathasan et al., 2005; 
Gavrilin et al., 2006). Only recently were the cytosolic sensors of 
F. tularensis identified. First it was shown that pyrin was essential 
for F. novicida-induced inflammasome activation within human 
monocytes (Gavrilin et al., 2009). Later studies with murine mac-
rophages led to two concurrently published reports showing that 
absent in melanoma 2 (AIM-2) was essential for inflammasome 
activation and that this was responsible for caspase-1 and IL-1β 
processing (Fernandes-Alnemri et al., 2010; Rathinam et al., 2010). 
These findings were later supported by another report (Jones et al., 
2010). However, human monocytes, which are robust producers 
of IL-1β during F. novicida infection (Gavrilin et al., 2006) do not 
express AIM-2 (Rathinam et al., 2010). Hence, it is likely that more 
than one cytosolic receptor is capable of responding to Francisella, 
and that these receptors may be cell- or species-specific.
the pi3K signaling pathway regulates host 
responses
PI3K signaling is known to regulate numerous cellular processes 
such as autophagy (Petiot et al., 2000), phagocytosis (Araki et al., 
1996), cell survival, oxidative burst (Chen et al., 2003; Hoyal et al., 
2003), and inflammatory cytokine production (Parsa et al., 2006). 
There are three classes of PI3K, which differ in the products that 
they produce and thereby drive different cellular functions. Class I 
PI3K convert PI(4,5)P
2
 to PI(3,4,5)P
3
, which then serves as a second 
messenger and can activate protein kinase B/Akt (Vanhaesebroeck 
et al., 1997). This signaling pathway can be activated by a variety 
of cell surface receptors such as Fc receptors (Marshall et al., 2001), 
TLR (Laird et al., 2009), and the insulin receptor (Lavan et al., 1992). 
Our laboratory has shown that PI3K (Parsa et al., 2006) and Akt 
(Rajaram et al., 2006) positively regulate transcriptional activity of 
NF-κB in response to F. novicida within macrophages. Furthermore, 
Akt promotes the production of pro-inflammatory cytokines such as 
TNFα, IL-6, and IL-12, while inhibiting the production of the anti-
inflammatory cytokine IL-10. Studies in vivo have demonstrated that 
PI3K/Akt activation is host-protective. Compared to wild-type mice, 
mice expressing a macrophage-specific form of constitutively active 
Akt (MyrAkt) showed a survival advantage when challenged with 
Downstream signaling events implicated in the phagocytosis of 
F. novicida include the splenic tyrosine kinase (Syk) and extracel-
lular signal-regulated kinase (ERK) pathways. Genetic and phar-
macologic manipulation of these two kinases established that both 
pathways are required for macrophage phagocytosis of bacteria 
under heat-inactivated fetal bovine serum culture conditions (Parsa 
et al., 2008b). Conflicting reports exist on the role of PI3K signaling 
during phagocytosis. Phagocytosis of F. tularensis in human mono-
cyte derived macrophages cultured in AB serum is wortmannin 
sensitive (Clemens and Horwitz, 2007). However, PI3K or down-
stream Akt signaling in murine macrophages cultured with heat-
inactivated fetal bovine serum does not have any effect on bacterial 
internalization (Parsa et al., 2008b; Rajaram et al., 2009).
intracellular replication
Intracellular replication requires escape from the phagosome to 
gain access to the cytosol. Numerous escape/replication deficient 
mutants of F. novicida have been generated (Lauriano et al., 2004; 
Santic et al., 2005, 2007; Mohapatra et al., 2008). Studies with these 
mutants have shown that Francisella manipulates host signaling 
in at least two distinct ways to promote intracellular proliferation. 
Firstly, Francisella inhibits protective responses that would promote 
bacterial clearance. For example, it has been shown that F. novicida 
induces suppressor of cytokine signaling 3 (SOCS3) expression 
to interfere with IFNγ-mediated activation of STAT1, which con-
tributes to the intracellular killing of bacteria (Parsa et al., 2008a). 
Hence, although IFNγ itself is upregulated following Francisella 
infection (Butchar et al., 2007, 2008), its autocrine/paracrine activ-
ity would be minimal. Along with manipulating these downstream 
mediators, it was shown that Francisella can regulate expression of 
the interferon gamma receptor (IFNγR) itself. Infection with the 
novicida and tularensis subspecies (Butchar et al., 2008) as well as 
with holarctica (unpublished observations) leads to downregula-
tion of the IFNγR in human monocytes, and F. novicida infection 
of RAW264.7 murine macrophages induces downregulation of the 
IFNγR alpha chain (Roth et al., 2009).
A second way by which Francisella manipulates host signaling 
is to activate pathways that benefit bacterial replication. Recently 
it was shown that host signaling through Ras, SOS2, GrB2, PKCα, 
and PKCβI promotes host cell survival and maintenance of the rep-
licative niche for F. novicida (Al Khodor and Abu Kwaik, 2010). In 
another study, a forward genetics screen identified USP22, CDC27, 
and PI4KCA as host factors required for intracellular replication 
of F. novicida (Akimana et al., 2010). Hence, Francisella is capable 
not only of suppressing host responses, but also of manipulating 
the host environment to facilitate its own survival and replica-
tion. Without either of these general mechanisms, it is unlikely that 
Francisella would succeed as an intracellular pathogen.
autophagy: re-entry into the endocytic pathway
At the late stages of infection, cytosolic F. tularensis LVS becomes 
enclosed within vacuoles that resemble autophagosomes. This has 
been conclusively shown in murine macrophages (Checroun et al., 
2006), and there is some evidence that it also occurs in human 
monocytic cells (Mohapatra et al., 2008). Detailed functional con-
sequences of autophagy have yet to be elucidated, but it has been 
shown that human monocytes treated with an autophagy-inducing 
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phosphatase regulation of host response to 
Francisella
PIP3 levels are antagonized by the regulatory phosphatases PTEN 
that converts PI(3,4,5)P
3
 back to PI(4,5)P
2
, and SH2 domain-
 containing inositol 5′-phosphatase 1 (SHIP) that converts 
PI(3,4,5)P
3
 to PI(3,4)
2
. By these actions, both phosphatases nega-
tively regulate Akt activation. Our laboratory has shown that SHIP 
is phosphorylated in response to Francisella. Consequently, SHIP 
represses the production of pro-inflammatory cytokines (Parsa 
et al., 2006), phagosome maturation, and macrophage survival 
(Rajaram et al., 2009). This is consistent with to role of Akt in 
promoting these functions within the host. We also found that 
SHIP expression is strongly downregulated during infection with 
the low-virulence F. novicida subspecies but not with the more 
virulent F. tularensis subspecies (Cremer et al., 2009b). This is 
likely a contributing factor to the lack of inflammatory response 
during F. tularensis infection (Bosio et al., 2007; Butchar et al., 
2008; Cremer et al., 2009b).
Recently it has been reported that infection with the viru-
lent F. tularensis SCHU S4 increases expression and activation 
of phosphatase and tensin homolog (PTEN), an effect brought 
about by the production of antioxidants from the bacterium 
(Melillo et al., 2010). Hence, F. tularensis appears to use both 
phosphatases – PTEN and SHIP – to dampen PI3K signaling. 
The idea that F. tularensis does so through presumably different 
mechanisms (upregulation of PTEN versus inhibiting downregu-
lation of SHIP) further highlights the intricacies and complexities 
of this pathogen.
Bacterial disruption of host signaling
Many bacterial pathogens are known to secrete factors that disrupt 
host signaling proteins. Because of the numerous examples showing 
that microbes inhibit Akt activation (Celli et al., 2001; Wiles et al., 
2008; Popova et al., 2009), components of the PI3K/Akt pathway 
may soon come to light as potential therapeutic targets. During 
the infection cycle of Francisella there is initial contact with the 
host cell and containment within a phagosome, then escape of the 
bacteria into the cytosol. Our laboratory has seen that there is initial 
phosphorylation/activation of Akt followed by decline to a more 
inactivated state, but infection with mutants of Francisella that 
cannot escape from phagosome results in sustained Akt activation 
(Rajaram et al., 2006). This is specific in the sense that the same 
activation – inactivation phenomenon is not seen with phosphor-
ylation/activation of the MAPKs (ERK, JNK, and p38). Therefore, it 
appears that Francisella specifically targets the PI3K/Akt pathway.
Along with PI3K/Akt regulation, Francisella dampens other sig-
naling pathways such as MAPK and the inflammasome. Recently it 
has been shown that ripA of Francisella inhibits MAPK activation, 
which subsequently inhibits the production of TLR-dependent and 
inflammasome-dependent pro-inflammatory cytokines (Huang 
et al., 2010). This bacterial factor also promotes intracellular rep-
lication, presumably though its inhibition of host response. Another 
recent report shows that the bacterial protein mviN inhibits AIM-2 
inflammasome activation in murine macrophages infected with 
LVS (Ulland et al., 2010). Hence, Francisella dampens host response 
on many fronts, and further work will undoubtedly uncover other 
such mechanisms.
a lethal dose of F. novicida (Rajaram et al., 2006). There was also a 
reduced bacterial burden in the MyrAkt mice. This activated Akt was 
found to promote phagosome maturation, thus inhibiting bacterial 
escape and replication. Related to this, we found that macrophages 
from MyrAkt mice showed reduced Fas-induced caspase-3 death 
after infection. Because phagosomal escape mutants of Francisella 
do not induce Fas nor activate caspase-3 (Rajaram et al., 2009), it 
is likely that bacterial escape or perhaps stress from bacterial repli-
cation triggers apoptosis. Caspase-3-mediated death appears to be 
of major importance, as the highly virulent subspecies F. tularen-
sis activates caspase-3 and not caspase-1 (Wickstrum et al., 2009). 
Interestingly, the virulent F. tularensis specifically downregulates 
host cell TLR2, PI3K p85α, and Akt expression (Butchar et al., 2008), 
which should result in suboptimal activation of the host-protective 
PI3K/Akt pathway. This is in line with earlier work showing that F. 
tularensis infection elicits minimal to no observable response in vivo 
during early stages of infection (Bosio et al., 2007). This ability to 
infect without eliciting an immune response confers a stealth-like 
nature to Francisella (Sjostedt, 2006).
A downstream target of Akt that has also been investigated 
within the context of Francisella is glycogen synthase kinase 3 beta 
(GSK3β). This molecule is normally active in the cell until inacti-
vated by Akt (Sutherland et al., 1993; Sutherland and Cohen, 1994). 
Thus, increased Akt activity results in decreased GSK3β activity. It 
has been found that inhibiting GSK3β in vivo results in increased 
host survival in mice. This is consistent with the role of Akt as host-
protective. However, published data on GSK3β indicates that this 
molecule is required for pro-inflammatory response and concur-
rently inhibits anti-inflammatory IL-10 production (Zhang et al., 
2009). This might be expected because GSK3β has been shown to be 
required for NF-κB activation (Hoeflich et al., 2000). Other work, 
however, has shown that GSK3β can repress NF-κB activity and 
nuclear translocation as well as cytokine production (Vines et al., 
2006; Escribano et al., 2009; Saijo et al., 2009; Beurel et al., 2010). 
Taken together, these results suggest that the function of GSK3β 
may be highly context-specific.
 Although these results suggest that PI3K activity is beneficial 
to the host during Francisella infection, there is also evidence that 
it may be detrimental. Medina et al. (2010) reported that treat-
ment with wortmannin, a PI3K inhibitor, led to increased ERK 
and p38 phosphorylation as well as enhanced TNFα and IL-6 
production in murine bone marrow-derived macrophages fol-
lowing infection with the LVS of Francisella. They also found a 
PI3K-mediated upregulation of the MAPK inhibitor MKP-1, which 
likely led to much of the MAPK inhibition (Medina et al., 2010). 
MKP-1 is upregulated in human monocytes following infection 
with the novicida, holarctica, and tularensis subspecies of Francisella 
(Butchar et al., 2008 and unpublished observations), so may not 
fully explain the observed discrepancies. However, as pointed out 
by Medina et al. (2010), differences in subspecies and/or culture 
conditions of this facultative bacterium might account for this. For 
example, the LPS of F. novicida elicits a greater immune response 
than that of LVS (Kieffer et al., 2003). More broadly, differences in 
cellular context (e.g., maturation state) as well as in both strength 
and type of stimulus can determine whether and to what extent 
PI3K activity can inhibit ERK (Rommel et al., 1999; Zimmermann 
and Moelling, 1999; Moelling et al., 2002).
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microrna regulation
MicroRNAs (miRs) have been shown to be key regulators of host 
functions that influence viral persistence (Gottwein and Cullen, 
2008). However, only a few studies address miRs within the field of 
bacterial pathogenesis, leaving open a potentially fruitful avenue of 
investigation. Early studies showed that pathogen associated molec-
ular patterns such as LPS could induce the expression of selected 
miRs such as miR-155, miR-146, and miR-132 (Taganov et al., 2006; 
O’Connell et al., 2007). MiR-155 has been of considerable interest 
since it was shown that this miR is required for B-cell maturation, 
normal T-cell function, dendritic cell antigen presentation, and 
inflammatory response (Rodriguez et al., 2007; Thai et al., 2007; 
O’Connell et al., 2010).
MiR-155 is of relevance to Francisella infection because this miR 
negatively regulates SHIP expression, which in turn regulates Akt and 
multiple host responses. Our laboratory found that miR-155 expres-
sion is highly induced in monocytes/macrophages infected with the 
low-virulence F. novicida. This was also found to occur in vivo within 
48 h in mice given a lethal dose of F. novcidia. The induction of this 
miR required TLR signaling and NF-κB activation. Genetic manipu-
lation showed that miR-155 modulates the inflammatory response by 
promoting TNFα and IL-6 production (Cremer et al., 2009b). This is 
logical given that miR-155 represses SHIP, which represses Akt activa-
tion and the production of pro-inflammatory mediators in response 
to F. novicida (Parsa et al., 2006). Importantly, although miR-155 is 
highly induced upon infection with low-virulence F. novicida it is 
minimally induced with high-virulence F. tularensis. These results 
support the consensus that virulent forms of Francisella subvert and 
suppress host immune responses, as the lack of miR-155 with the 
virulent F. tularensis will result in higher levels of the inhibitory SHIP. 
Hence, host cell Akt activation is impaired through at least three 
mechanisms: downregulation of PI3K/Akt pathway members, the 
bacterial antioxidant system, and miR-155. A model summarizing 
these findings is shown in Figure 1.
conclusion
This review has highlighted recent advances in our understanding 
of host response to Francisella. Research on this pathogen has been 
at an all time high in the recent years and great progress has been 
made. Not only is there interest in studying this pathogen due to its 
highly virulent nature, it has also become a useful tool for studying 
various aspects of the immune system. Here, we have discussed sev-
eral critical host signaling pathways that Francisella manipulates in 
order to subvert normal pro-inflammatory responses. Importantly, 
the idea that miRs play key roles – as mediators of host response and 
as targets of Francisella – has begun to surface, and this may open 
FIguRe 1 | Francisella tularensis tularensis targets the PI3K/Akt pathway 
at multiple levels. Blue represents downregulated genes, red upregulated, 
white unchanged, and gray the resulting cellular outcomes. TLR2 is required 
for full PI3K activation by Francisella, which in turn activates Akt. Active Akt 
promotes NF-κB activation and cytokine production, as well as phagosome 
maturation and host cell survival. However, the phosphatases SHIP and PTEN 
antagonize this Akt activation. SHIP expression is inhibited by miR-155, which 
is induced by the low-virulence but not high-virulence subspecies of 
Francisella. This lack of miR-155 induction by the high-virulence subspecies 
leads to maintenance of SHIP levels. The other phosphatase PTEN is 
upregulated and maintained in a highly active state upon infection with 
high-virulence Francisella.
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